RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SEREGNI E
Collezione AOU San Luigi di Orbassano

Items : 3

Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. in Advances in therapy / Adv Ther. 2024 Jan;41(1):113-129. doi: 10.1007/s12325-023-02714-8. Epub 2023 Nov 21.

2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Stasi M; Volante M; Seregni E; Santimaria M; Schillaci O; Panzuto F; Milione M; Grimaldi F; Giordano A; D'Onofrio M; Ferone D; Bartolomei M; Berruti A; Foglia E; Falconi M; Fazio N; Lastoria S; Fazio N; Falconi M; Foglia E; Bartolomei M; Berruti A; D'Onofrio M; Ferone D; Giordano A; Grimaldi F; Milione M; Panzuto F; Santimaria M; et alii...

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. in Endocrine-related cancer / Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.

2018
AOU San Luigi di Orbassano

Pusceddu S; Barretta F; Trama A; Botta L; Milione M; Buzzoni R; De Braud F; Mazzaferro V; Pastorino U; Seregni E; Mariani L; Gatta G; Di Bartolomeo M; Femia D; Prinzi N; Coppa J; Panzuto F; Antonuzzo L; Bajetta E; Brizzi MP; Campana D; Catena L; Comber H; Dwane F; Fazio N; Faggiano A; Giuffrida D; Henau K; Ibrahim T; et alii...